International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 4 , Pages 1147-1155 , 15 November 2010

Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma

  • Michael T. Milano, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY
    • Corresponding Author InformationReprint requests to: Michael T. Milano, M.D., Ph.D., Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Ave, Box 647, Rochester, NY 14642. Tel: (585) 273-4096; Fax: (585) 275-1531
    • ,
  • Paul Okunieff, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY
    • ,
  • Rosemary S. Donatello, C.M.D.

      Affiliations

    • Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY
    • ,
  • Nimish A. Mohile, M.D.

      Affiliations

    • Department of Neurology, University of Rochester Medical Center, Rochester, NY
    • ,
  • Joohee Sul, M.D.

      Affiliations

    • Department of Neurology, University of Rochester Medical Center, Rochester, NY
    • National Cancer Institute, Rockville, MD
    • ,
  • Kevin A. Walter, M.D.

      Affiliations

    • Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY
    • Department of Medicine, Division of Oncology, University of Rochester Medical Center, Rochester, NY
    • ,
  • David N. Korones, M.D.

      Affiliations

    • Department of Medicine, Division of Oncology, University of Rochester Medical Center, Rochester, NY
    • Department of Pediatrics, University of Rochester Medical Center, Rochester, NY

Received 1 July 2009 ,Revised 1 September 2009 ,Accepted 2 September 2009.

References 

  1. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979;5:1725–1731
  2. Stewart LA. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011–1018
  3. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
  4. Halperin EC, Bentel G, Heinz ER, et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys. 1989;17:1347–1350
  5. Earnest Ft, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology. 1988;166:823–827
  6. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980;30:907–911
  7. Wallner KE, Galicich JH, Krol G, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989;16:1405–1409
  8. Bashir R, Hochberg F, Oot R. Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery. 1988;23:27–30
  9. Liang BC, Thornton AF, Sandler HM, et al. Malignant astrocytomas: Focal tumor recurrence after focal external beam radiation therapy. J Neurosurg. 1991;75:559–563
  10. Garden AS, Maor MH, Yung WK, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol. 1991;20:99–110
  11. Gaspar LE, Fisher BJ, Macdonald DR, et al. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys. 1992;24:55–57
  12. Hess CF, Schaaf JC, Kortmann RD, et al. Malignant glioma: Patterns of failure following individually tailored limited volume irradiation. Radiother Oncol. 1994;30:146–149
  13. Oppitz U, Maessen D, Zunterer H, et al. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol. 1999;53:53–57
  14. Lee SW, Fraass BA, Marsh LH, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study. Int J Radiat Oncol Biol Phys. 1999;43:79–88
  15. Aydin H, Sillenberg I, von Lieven H. Patterns of failure following CT-based 3-D irradiation for malignant glioma. Strahlenther Onkol. 2001;177:424–431
  16. Park I, Tamai G, Lee MC, et al. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys. 2007;69:381–389
  17. Brandes AA, Tosoni A, Franceschi E, et al. Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: Correlation with MGMT promoter methylation status. J Clin Oncol. 2009;27:1275–1279
  18. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 1991;64:769–774
  19. Nakagawa K, Aoki Y, Fujimaki T, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40:1141–1149
  20. Fitzek MM, Thornton AF, Rabinov JD, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial. J Neurosurg. 1999;91:251–260
  21. Mehta MP, Masciopinto J, Rozental J, et al. Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys. 1994;30:541–549
  22. Loeffler JS, Alexander E, Hochberg FH, et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990;19:1455–1462
  23. Agbi CB, Bernstein M, Laperriere N, et al. Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiat Oncol Biol Phys. 1992;23:321–326
  24. Sneed PK, Gutin PH, Larson DA, et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys. 1994;29:719–727
  25. Aiken AH, Chang SM, Larson D, et al. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy. Int J Radiat Oncol Biol Phys. 2008;72:1340–1346
  26. Mangla R, Singh G, Ziegelitz D, et al. Change in relative cerebral blood volume one month after radiation/temozolomide predicts overall survival in patients with glioblastoma. Radiology. In press.
  27. Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26:2192–2197
  28. Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453–461
  29. Taal W, Brandsma D, de Bruin HG, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer. 2008;113:405–410
  30. Korones D, Okunieff P, Milano M. Accelerated radiotherapy and temozolomide in adults with newly diagnosed glioblastoma multiforme: A pilot study. J Clin Oncol. 2008;26:abstract 13014
  31. Lee IH, Piert M, Gomez-Hassan D, et al. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009;73:479–485
  32. Wick W, Stupp R, Beule AC, et al. A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro Oncol. 2008;10:1019–1024
  33. Parsa AT, Wachhorst S, Lamborn KR, et al. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg. 2005;102:622–628
  34. Potthast L, Chowdhary S, Pan E, et al. The infiltrative, diffuse pattern of recurrence in patients with malignant gliomas treated with bevacizumab. J Clin Oncol. 2009;27:abstract 2057
  35. Zuniga RM, Torcuator R, Jain R, et al. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. J Neurooncol. 2009;91:329–336
  36. Norden AD, Young GS, Setayesh K, et al. Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence. Neurology. 2008;70:779–787
  37. Amberger VR, Hensel T, Ogata N, et al. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998;58:149–158
  38. Tatenhorst L, Puttmann S, Senner V, et al. Genes associated with fast glioma cell migration in vitro and in vivo. Brain Pathol. 2005;15:46–54
  39. Krishnan AP, Asher IM, Davis D, et al. Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors. Int J Radiat Oncol Biol Phys. 2008;71:1553–1562

 Conflict of interest: none.

PII: S0360-3016(09)03211-8

doi: 10.1016/j.ijrobp.2009.09.018

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 4 , Pages 1147-1155 , 15 November 2010

Article Tools

* Image Usage & Resolution